Today's Wall Street Journal has this article about the proposed new legislation, dubbed Bioshield II, designed to create incentives for medical research and development, targeted mainly at bioterrorism agents but also including infectious diseases.
Richard Kogan is a Senior Fellow at the Center on Budget Policy and Priorities, specializing in federal budget issues, including aggregate spending, revenues, surpluses and deficits, and debt. He is also an expert in the congressional and executive budget processes and budget accounting concepts. He served for twenty years on the staff of the Committee on the Budget of the U.S.
A four year study of a pneumococcal vaccine in the Gambia, published today's The Lancet (free registration), finds that the vaccine reduced childhood mortality by 16 percent in children who received the pneumococcal conjugate vaccine.
Dr. Lee Jong-wook, the Director-General of the World Health Organization (WHO) said: